These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 35654244)

  • 1. Drug repositioning for cancer in the era of AI, big omics, and real-world data.
    Wieder R; Adam N
    Crit Rev Oncol Hematol; 2022 Jul; 175():103730. PubMed ID: 35654244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence unifies knowledge and actions in drug repositioning.
    Yin Z; Wong STC
    Emerg Top Life Sci; 2021 Dec; 5(6):803-813. PubMed ID: 34881780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of artificial intelligence in drug development using real-world data.
    Chen Z; Liu X; Hogan W; Shenkman E; Bian J
    Drug Discov Today; 2021 May; 26(5):1256-1264. PubMed ID: 33358699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
    Cong Y; Endo T
    OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence, machine learning, and drug repurposing in cancer.
    Tanoli Z; Vähä-Koskela M; Aittokallio T
    Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
    [No Abstract]   [Full Text] [Related]  

  • 7. Explainable artificial intelligence in high-throughput drug repositioning for subgroup stratifications with interventionable potential.
    Al-Taie Z; Liu D; Mitchem JB; Papageorgiou C; Kaifi JT; Warren WC; Shyu CR
    J Biomed Inform; 2021 Jun; 118():103792. PubMed ID: 33915273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence and Cancer Drug Development.
    Yang F; Darsey JA; Ghosh A; Li HY; Yang MQ; Wang S
    Recent Pat Anticancer Drug Discov; 2022; 17(1):2-8. PubMed ID: 34323201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus.
    Lee S; Jeon S; Kim HS
    Endocrinol Metab (Seoul); 2022 Apr; 37(2):195-207. PubMed ID: 35413782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
    Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
    Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Artificial Intelligence-based Drug Discovery and Drug Repositioning].
    Tanaka H
    Brain Nerve; 2019 Sep; 71(9):981-989. PubMed ID: 31506400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence and the future of life sciences.
    Leite ML; de Loiola Costa LS; Cunha VA; Kreniski V; de Oliveira Braga Filho M; da Cunha NB; Costa FF
    Drug Discov Today; 2021 Nov; 26(11):2515-2526. PubMed ID: 34245910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potential for Big Data Analysis Using AI in the Field of Clinical Pharmacy].
    Kiryu Y
    Yakugaku Zasshi; 2021; 141(2):179-185. PubMed ID: 33518637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
    Tripathi N; Goshisht MK; Sahu SK; Arora C
    Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence in Pharmaceutical Field - A Critical Review.
    Shanbhogue MH; Thirumaleshwar S; Tegginamath PK; Somareddy HK
    Curr Drug Deliv; 2021; 18(10):1456-1466. PubMed ID: 34139981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence.
    Passamonti F; Corrao G; Castellani G; Mora B; Maggioni G; Gale RP; Della Porta MG
    Blood Rev; 2022 Jul; 54():100914. PubMed ID: 34996639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Repurposing Drugs and Identifying Contraindications from Real World Study in Parkinson's Disease.
    Tang Y; Yang K; Zhao J; Liang X; Wang J
    ACS Chem Neurosci; 2019 Feb; 10(2):954-963. PubMed ID: 30702853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma.
    Hayashi H; Uemura N; Matsumura K; Zhao L; Sato H; Shiraishi Y; Yamashita YI; Baba H
    World J Gastroenterol; 2021 Nov; 27(43):7480-7496. PubMed ID: 34887644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.